Make Your Case to Attend the 7th Genome Editing Therapeutics Summit
Attending the 7th Genome Editing Therapeutics Summit is an opportunity to stay ahead of the rapidly evolving genome editing landscape, gain practical insights from industry leaders, and bring back actionable strategies to strengthen your organization's development programs. The summit will unite R&D, translational, clinical, regulatory and executive leaders working to advance the next generation of genome editing therapeutics.
If your work involves CRISPR, base editing, prime editing, gene writing, delivery technologies, manufacturing, translational development, clinical translation, or regulatory strategy, this meeting offers highly relevant insights that can directly support your team's objectives.
Why This Meeting Matters to Your Organization
- Stay Ahead of Regulatory Change
Learn how companies are responding to the FDA's Plausible Mechanism Framework and evolving NGS safety guidance to accelerate clinical development while maintaining robust safety standards - De-Risk Development Decisions
Hear directly from leaders at companies including Intellia Therapeutics, Beam Therapeutics, Sanofi, AbbVie, Bristol Myers Squibb, Eli Lilly and Metagenomi Therapeutics as they share approaches to delivery, safety, manufacturing and clinical translation - Benchmark Your Strategy
Connect with the senior decision-makers building the next generation of genome editing medicines and compare your development strategy against peers tackling similar scientific, manufacturing and regulatory challenges - Accelerate Program Progress
Access practical case studies spanning in vivo and ex vivo genome editing approaches, analytical development, translational science and commercialization readiness - Build Valuable Partnerships
Identify potential collaborators, technology providers and service partners who can help overcome bottlenecks in delivery, characterization, manufacturing and clinical development
Who You Will Meet
With a speaker faculty of 86% Director-to-CXO CRISPR experts, the 7th Genome Editing Therapeutics Summit convenes a highly senior audience of decision-makers.
45%
Director & Head Of
30%
C-Suite
15%
Scientist
10%
Vice President
From Organizations Including:
Making Approval Easy: Example Justification Email
Subject: Approval Request to Attend the 7th Genome Editing Therapeutics Summit
Dear [Manager Name],
I am writing to request approval to attend the 7th Genome Editing Therapeutics Summit, taking place September 28-30, 2026, in Boston, MA. This meeting is dedicated to advancing safe, effective and scalable genome editing therapeutics, bringing together leaders across R&D, translational science, clinical development, manufacturing and regulatory affairs.
This year's agenda is closely aligned with our work in [Insert your area of responsibility], particularly our efforts related to [insert current project, team objective or strategic priority].
Several sessions cover topics directly relevant to our team's objectives, including safety, delivery, regulatory strategy, translational development and manufacturing readiness. These discussions would provide valuable insight into industry best practices and emerging approaches being adopted across the field.
By attending, I would be able to:
- Gain insight into the latest scientific, clinical and regulatory developments impacting genome editing programs
- Learn from industry leaders and organizations actively advancing genome editing therapeutics
- Benchmark our current approach against peer organizations addressing similar challenges
- Identify new technologies, solutions and potential partners relevant to our work
- Bring back practical insights that may help improve decision-making, efficiency and future planning
Specifically, I believe the knowledge gained could support our work on [Insert program, initiative or business objective].
Following the conference, I will ensure the value of attendance is shared across the team by:
- Preparing a summary report of key takeaways
- Sharing relevant presentations, insights and industry updates
- Presenting recommendations applicable to our current activities
- Highlighting potential opportunities, solutions or partnerships identified during the event
The conference attracts a highly senior audience and features speakers from leading organizations across the genome editing ecosystem. Attending will provide access to scientific, strategic and regulatory insights that may be difficult to obtain elsewhere.
I am confident that the knowledge, connections and best practices gained from this event will support both my professional development and our team's objectives, particularly as we continue to focus on [Insert team or company goal].
Thank you for considering my request. I would be happy to discuss the event in more detail and explain how attendance could support our wider business goals.
Kind regards,
[Your Name]
[Job Title]
[Company]
Need Help Building Your Case?
If you require additional information to support your approval request, we're happy to provide:
- Agenda recommendations tailored to your team and role
- Speaker and attendee insights
- Audience demographics
- Registration and pricing information
- A personalized ROI discussion
Explore the Agenda
See exactly which delivery, manufacturing and regulatory sessions are relevant to your genome editing program.
Partner With Us
Put your solutions in front of the genome editing decision-makers actively looking for them.
Join Genome Editing Experts
Connect with the R&D, clinical and regulatory leaders driving genome editing therapeutics forward.